Novavax stock jumps 50% as Sanofi deal kicks off turning point for struggling vaccine maker
Shares of Novavax jumped as much as 50% on Monday as Wall Street cheered the company's new multibillion-dollar deal with French drugmaker Sanofi that sparked a dramatic turnaround for the struggling vaccine maker.